xarelto

Xarelto Bellwether Cases Inch Closer to Court Dates

more xarelto cases set for trialIn 2011, the FDA approved a drug that many hoped would be the first step forward in blood thinning medication since Coumadin’s debut in the 1960s: Xarelto.

Created by Johnson & Johnson and Bayer, Xarelto has been responsible for over $3.2 billion in profits for its manufacturers and developers. It has also become Bayer’s top-selling medication ever. Yet despite its successes on paper, the reality is that more than 18,000 plaintiffs ...

continue reading...

Bellwether Xarelto Bleeding Case Ends With Defense Verdict

bellwether xarelto case ends in verdict for defenseFew drugs have taken the market by storm like Xarelto. Developed as an improvement over Coumadin; the ‘standard’ of blood thinning medications since the 1960s, Xarelto has seen billions of dollars in sales growth since its release in 2011. In fact, Xarelto sales more than doubled in the four-year span between 2013 and 2016, topping out at $3.2 billion in 2016. This makes it Bayer’s top-selling medication.

On the surface, ...

continue reading...

Real World Data Shows Stark Safety Contrast Between Xarelto and Pradaxa

real world numbers show xarelto dangers“A recent study indicated…” The phrase is used to introduce countless articles that report on the medical industry. This blog is no exception. Savvy consumers always have to be aware, however, of how those studies came to be. Who funded them? What was the exact question they sought to answer? What, if any, possible ulterior motives could exist for the creation of such a study? Information is there to be consumed ...

continue reading...

Xarelto Reversal Agent Succeeds in Late-Stage Trial

xarelto reversal agent closer to approvalReuters reports that andexanet alfa, a drug developed by Portola Pharmaceuticals to reverse the bleeding side effects of new oral anticoagulants like Xarelto, has proven successful in a late-stage clinical trial. Portola hopes the new data will help earn the antidote approval from the U.S. Food and Drug Administration.

Xarelto is a relatively new blood thinner that has made strides in the pharmaceutical industry since its introduction in 2011. The ...

continue reading...

First Federal Xarelto Lawsuit Trials Set for 2017

xarelto lawsuits set to start in 2017Judge Eldon Fallon of the U.S. District Court for the Eastern District of Louisiana has assigned early 2017 trial dates for the first four federal Xarelto lawsuits, Reuters reports. Currently, over 1,700 Xarelto bleeding lawsuits are pending in the Louisiana Xarelto MDL.

Xarelto was approved by the U.S. Food and Drug Administration (FDA) in 2011 for use as an anticoagulant in certain patients at risk for embolic events. The ...

continue reading...

Xarelto Approved in Japan for Thromboembolism, Deep Vein Thrombosis

xarelto approved for use in japanFinanzen reports that the anticoagulant Xarelto has been approved by the Japanese Ministry of Health, Labor, and Welfare for the treatment and secondary prevention of thromboembolism and deep vein thrombosis. Xarelto was already approved in Japan for prevention of stroke in patients with nonvalvular atrial fibrillation.

The U.S. Food and Drug Administration approved Xarelto in 2011 for treatment of pulmonary embolism and deep vein thrombosis in certain patients. Xarelto is ...

continue reading...
Page 1 of 5 12345